Presentation is loading. Please wait.

Presentation is loading. Please wait.

Thyroid function after controlled ovarian hyperstimulation in women with and without the hyperstimulation syndrome  Kris Poppe, M.D., Ph.D., David Unuane,

Published bySusanto Chandra Modified over 5 years ago

Similar presentations

Presentation on theme: "Thyroid function after controlled ovarian hyperstimulation in women with and without the hyperstimulation syndrome  Kris Poppe, M.D., Ph.D., David Unuane,"— Presentation transcript:

1 Thyroid function after controlled ovarian hyperstimulation in women with and without the hyperstimulation syndrome  Kris Poppe, M.D., Ph.D., David Unuane, M.D., Miguel D’Haeseleer, M.D., Herman Tournaye, M.D., Ph.D., Johan Schiettecatte, Patrick Haentjens, M.D., Ph.D., Brigitte Velkeniers, M.D., Ph.D.  Fertility and Sterility  Volume 96, Issue 1, Pages (July 2011) DOI: /j.fertnstert Copyright © 2011 American Society for Reproductive Medicine Terms and Conditions

2 Figure 1 Pattern of change over time for the mean TSH and free T4 (fT4) serum values collected at 4 time points: before ET (time 0) and at weeks 2, 4, and 6 after ET. P=not significant for patients with ovarian hyperstimulation syndrome (OHSS) (solid red lines) vs. no OHSS (dotted blue lines). Fertility and Sterility  , DOI: ( /j.fertnstert ) Copyright © 2011 American Society for Reproductive Medicine Terms and Conditions

Download ppt "Thyroid function after controlled ovarian hyperstimulation in women with and without the hyperstimulation syndrome  Kris Poppe, M.D., Ph.D., David Unuane,"

Similar presentations

What’s the delay? A qualitative study of women’s experiences of reaching a diagnosis of endometriosis  Karen Ballard, Ph.D., Karen Lowton, Ph.D., Jeremy.

What’s the delay? A qualitative study of women’s experiences of reaching a diagnosis of endometriosis  Karen Ballard, Ph.D., Karen Lowton, Ph.D., Jeremy.
Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles  Ryan G. Steward,

Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles  Ryan G. Steward,
Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome

Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome
Age at menarche: a predictor of diminished ovarian function?

Age at menarche: a predictor of diminished ovarian function?
Local injury to the endometrium in controlled ovarian hyperstimulation cycles improves implantation rates  Liang Zhou, M.D., Rong Li, M.D., Ph.D., Rong.

Local injury to the endometrium in controlled ovarian hyperstimulation cycles improves implantation rates  Liang Zhou, M.D., Rong Li, M.D., Ph.D., Rong.
Daily physical activity and hot flashes in the Study of Women's Health Across the Nation (SWAN) Flashes Study  Carolyn Gibson, M.P.H., M.S., Karen Matthews,

Daily physical activity and hot flashes in the Study of Women's Health Across the Nation (SWAN) Flashes Study  Carolyn Gibson, M.P.H., M.S., Karen Matthews,
The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition  Lorraine Dennerstein,

The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition  Lorraine Dennerstein,
No difference in cycle pregnancy rate and in cumulative live-birth rate between women with surgically treated minimal to mild endometriosis and women.

No difference in cycle pregnancy rate and in cumulative live-birth rate between women with surgically treated minimal to mild endometriosis and women.
Fernando Zegers-Hochschild, M.D.  Fertility and Sterility 

Fernando Zegers-Hochschild, M.D.  Fertility and Sterility 
Michael M. Alper, M.D.  Fertility and Sterility 

Michael M. Alper, M.D.  Fertility and Sterility 
Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm.

Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm.
Hepatitis and reproduction

Hepatitis and reproduction
The spectrum of androgen excess disorders

The spectrum of androgen excess disorders
Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) in IVF patients with polycystic ovary syndrome: correlations with outcome 

Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) in IVF patients with polycystic ovary syndrome: correlations with outcome 
Robot-assisted laparoscopy for infertility treatment: current views

Robot-assisted laparoscopy for infertility treatment: current views
Ethnicity as a determinant of ovarian reserve: differences in ovarian aging between Spanish and Indian women  Carlos Iglesias, M.D., Manish Banker, M.D.,

Ethnicity as a determinant of ovarian reserve: differences in ovarian aging between Spanish and Indian women  Carlos Iglesias, M.D., Manish Banker, M.D.,
Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study  Nicole Hope, M.B., B.S., Hon., Luk.

Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study  Nicole Hope, M.B., B.S., Hon., Luk.
Effect of the initiation of progesterone supplementation in in vitro fertilization–embryo transfer outcomes: a prospective randomized controlled trial 

Effect of the initiation of progesterone supplementation in in vitro fertilization–embryo transfer outcomes: a prospective randomized controlled trial 
Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study  Angela Kerchner, B.A., Whitney Lester,

Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study  Angela Kerchner, B.A., Whitney Lester,
Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels 

Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels 

Similar presentations

Ads by Google